Yan Li

7.3k total citations · 1 hit paper
207 papers, 4.4k citations indexed

About

Yan Li is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yan Li has authored 207 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 59 papers in Molecular Biology and 51 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yan Li's work include Gastric Cancer Management and Outcomes (25 papers), Lung Cancer Treatments and Mutations (17 papers) and Colorectal Cancer Treatments and Studies (13 papers). Yan Li is often cited by papers focused on Gastric Cancer Management and Outcomes (25 papers), Lung Cancer Treatments and Mutations (17 papers) and Colorectal Cancer Treatments and Studies (13 papers). Yan Li collaborates with scholars based in China, United States and Ethiopia. Yan Li's co-authors include Lin Shen, Ming Lu, Ying Yang, Chun‐Wei Peng, Guifang Yang, Jifang Gong, Huifang Zhu, Xiaojun Yang, Xiaolin Liu and Kenneth E. McMartin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Yan Li

195 papers receiving 4.4k citations

Hit Papers

Hepatogastroenterology 2011 2026 2016 2021 2011 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yan Li 1.5k 1.5k 1.0k 976 770 207 4.4k
Martin Schneider 1.6k 1.0× 915 0.6× 661 0.6× 795 0.8× 908 1.2× 163 3.8k
Hong Shen 1.1k 0.7× 2.1k 1.4× 770 0.8× 523 0.5× 1.0k 1.3× 172 4.4k
Chao Liu 2.0k 1.3× 1.7k 1.1× 817 0.8× 531 0.5× 861 1.1× 223 4.5k
Péter Fritz 2.0k 1.3× 1.8k 1.2× 1.4k 1.4× 864 0.9× 789 1.0× 133 6.4k
Anita L. Sabichi 1.2k 0.8× 1.5k 1.1× 1.1k 1.1× 803 0.8× 574 0.7× 90 4.4k
Shoichi Hazama 2.1k 1.4× 1.7k 1.2× 579 0.6× 668 0.7× 725 0.9× 187 4.5k
Roman A. Blaheta 1.0k 0.7× 2.5k 1.7× 663 0.7× 797 0.8× 581 0.8× 208 5.1k
Xinwei Han 1.8k 1.1× 1.7k 1.2× 1.4k 1.4× 489 0.5× 999 1.3× 175 4.6k
Sarangarajan Ranganathan 777 0.5× 1.8k 1.2× 566 0.6× 1.0k 1.1× 692 0.9× 178 4.4k
Junichi Nishimura 1.3k 0.8× 2.2k 1.5× 872 0.9× 1.3k 1.4× 979 1.3× 207 5.4k

Countries citing papers authored by Yan Li

Since Specialization
Citations

This map shows the geographic impact of Yan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Li more than expected).

Fields of papers citing papers by Yan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Li. The network helps show where Yan Li may publish in the future.

Co-authorship network of co-authors of Yan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Li. A scholar is included among the top collaborators of Yan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Li. Yan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Guo, Yaxin, Yi Zhang, Nuo Chen, et al.. (2024). IL-37d enhances COP1-mediated C/EBPβ degradation to suppress spontaneous neutrophil migration and tumor progression. Cell Reports. 43(2). 113787–113787. 4 indexed citations
6.
Liu, Dan, Jifang Gong, Zhi‐Qiang Wang, et al.. (2023). Pyrotinib alone or in combination with docetaxel in refractory HER2‐positive gastric cancer: A dose‐escalation phase I study. Cancer Medicine. 12(9). 10704–10714. 9 indexed citations
7.
Hu, Liang, Fan Hu, Chaoyu Wang, et al.. (2022). NET-Triggered NLRP3 Activation and IL18 Release Drive Oxaliplatin-Induced Peripheral Neuropathy. Cancer Immunology Research. 10(12). 1542–1558. 25 indexed citations
8.
Lu, Xinli, et al.. (2022). Identification of a New HIV-1 CRF68_01B/CRF01_AE Recombinant Form Among Men Who Have Sex with Men in Hebei Province, China. AIDS Research and Human Retroviruses. 38(10). 817–821. 2 indexed citations
9.
Liu, Yang, et al.. (2022). Identification of Three Novel HIV-1 Second-Generation Recombinant Forms (CRF01_AE/CRF07_BC) Among Men Who Have Sex with Men in Baoding, Hebei, China. AIDS Research and Human Retroviruses. 38(10). 812–816. 6 indexed citations
10.
Wang, Xinhua, Yuanzheng Liang, Wencai Li, et al.. (2021). Hydroa vacciniforme‐like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. The Journal of Dermatology. 48(9). 1315–1326. 3 indexed citations
11.
Du, Fengying, Li Han, Yan Li, et al.. (2021). Identification of m6A Regulator-Associated Methylation Modification Clusters and Immune Profiles in Melanoma. Frontiers in Cell and Developmental Biology. 9. 761134–761134. 8 indexed citations
12.
Huang, Yuhua, Chris Zhiyi Zhang, Joe Yeong, et al.. (2020). Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma. Journal of Hepatology. 74(4). 838–849. 69 indexed citations
13.
Shen, Jie, Ling Yuan, Yang Yan, et al.. (2020). A novel device to capture circulating tumor cells: Quantification and molecular analysis in lung cancer patients. Journal of Biomaterials Applications. 35(1). 49–58. 2 indexed citations
14.
Wang, Rui, Yan Li, Shouzhen Chen, et al.. (2018). CCL17‐CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer. Journal of Cellular Biochemistry. 120(2). 1979–1989. 21 indexed citations
15.
Li, Yan, Xiaobing Fu, Fang Yang, et al.. (2018). [Economic burden of hepatitis C patients and related influencing factors in Guangdong province].. PubMed. 39(7). 931–936.
16.
Tang, Yin, Zhuo Wang, Ziming Li, et al.. (2017). High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients. Proceedings of the National Academy of Sciences. 114(10). 2544–2549. 58 indexed citations
17.
Li, Yan, et al.. (2015). [Clinical observasion of acupuncture in patients with depression and its impact on serum 5-HT].. PubMed. 35(2). 123–6. 3 indexed citations
18.
Kong, Jienan, Yan Li, Shuangping Liu, et al.. (2013). High expression of ezrin predicts poor prognosis in uterine cervical cancer. BMC Cancer. 13(1). 520–520. 44 indexed citations
19.
Peng, Chun‐Wei, Lin‐Wei Wang, Min Fang, et al.. (2013). Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer. Journal of Translational Medicine. 11(1). 153–153. 27 indexed citations
20.
Yang, Xueqin, Xinghuan Wang, Chuang Chen, et al.. (2011). High Ki-67 expression is a poor prognostic indicator of 5-year recurrence free survival in patients with invasive breast cancer.. PubMed. 12(11). 3101–5. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026